Salvage use of allogeneic HSCT after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the EBMT Chronic Malignancies Working Party.

Date publication

avril 2017

Journal

Haematologica

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LIOURE Bruno

Tous les auteurs :
Sobh M, Michallet M, Dubois V, Iacobelli S, Koster L, Van Biezen A, Fegueux N, Tabrizi R, Finke J, El-Cheikh J, Schipperus M, Meijer E, von dem Borne P, Petersen E, Russell N, Tholouli E, Passweg J, Garban FR, Maertens J, Chevalier P, Maillard N, Volin L, Francois S, Lioure B, Beguin Y, Gluckman E, Ruggeri A, Garderet L, Kröger N

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28428268

Mots clés

Adult, Female, Graft vs Host Disease, etiology, Hematopoietic Stem Cell Transplantation, methods, Humans, Male, Middle Aged, Multiple Myeloma, diagnosis, Neoplasm Recurrence, Local, Survival Analysis, Transplantation Conditioning, methods, Transplantation, Homologous, Treatment Outcome, Unrelated Donors, Young Adult

Référence

Haematologica. 2017 Apr;: